Multimodality functional imaging in cancer treated with radiotherapy
Functional imaging has many potential uses in cancer: as a predictive biomarker, for directing radiotherapy or targeted systemic therapy and in assessment of response. However, these have to date found limited use clinically. The investigation of both established imaging methods (perfusion CT and MRI, FMISO- and FDG-PET) and novel functional imaging techniques (CEST and oxygen-enhanced MRI) through longitudinal imaging studies of patients undergoing radiotherapy will be presented. Comparison with histopathological assessment and the potential to combine imaging with genetic data to provide a tailored management plan for patients with cancer will be discussed
Date:
31 October 2017, 13:00 (Tuesday, 4th week, Michaelmas 2017)
Venue:
Old Road Campus Research Building, Headington OX3 7DQ
Venue Details:
Room 71a, b & c
Speaker:
Dr Tessa Greenhalgh (University of Oxford)
Organising department:
Department of Oncology
Organisers:
Dr Claire Butler (University of Oxford),
Anne-Marie Honeyman-Tafa (University of Oxford)
Organiser contact email address:
anne-marie-honeyman-tafa@oncology.ox.ac.uk
Part of:
CRUK & EPSRC Cancer Imaging Centre in Oxford
Booking required?:
Not required
Audience:
Public
Editor:
Anne-Marie Honeyman-Tafa
